Genedx Announced It Will Present New Data On Urine Mitochondrial DNA Testing At The 2023 United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium In North Carolina
Portfolio Pulse from Benzinga Newsdesk
GeneDx, a genetic testing company, has announced that it will present new data on urine mitochondrial DNA testing at the 2023 United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium in North Carolina.
June 28, 2023 | 11:13 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GeneDx's announcement of presenting new data on urine mitochondrial DNA testing could potentially impact the stock of WGS, if they are involved in the research or application of this technology.
The news does not directly mention WGS's involvement in GeneDx's research or application of urine mitochondrial DNA testing. Therefore, the potential impact on WGS's stock is uncertain at this point.
CONFIDENCE 50
IMPORTANCE 50
RELEVANCE 50